Literature DB >> 2895883

Recombinant human granulocyte-macrophage colony-stimulating factor produces fever.

W P Peters, J Shogan, E J Shpall, R B Jones, C S Kim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2895883     DOI： 10.1016/s0140-6736(88)91771-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Preclinical and clinical studies with the hematopoietic colony-stimulating factors and related interleukins.

Authors:  H E Broxmeyer; S Vadhan-Raj
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 2.  Clinical toxicity of cytokines used as haemopoietic growth factors.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

3.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 4.  The multifaceted effects of granulocyte colony-stimulating factor in immunomodulation and potential roles in intestinal immune homeostasis.

Authors:  Andrew Martins; Jiahuai Han; Sung O Kim
Journal:  IUBMB Life       Date:  2010-08       Impact factor: 3.885

5.  The potential role of recombinant hematopoietic colony-stimulating factors in preventing infections in the immunocompromised host.

Authors:  J Rusthoven
Journal:  Can J Infect Dis       Date:  1991

Review 6.  The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.

Authors:  Der-Cherng Liang
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.